Page last updated: 2024-12-06

tritoqualine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tritoqualine is a synthetic small-molecule compound that has shown promise as a potential therapeutic agent for various neurological disorders. Its mechanism of action involves modulating the activity of NMDA receptors, which are crucial for synaptic plasticity and learning. Studies have demonstrated that tritoqualine possesses neuroprotective properties, reducing neuronal damage and promoting neuronal survival in animal models of stroke and traumatic brain injury. Furthermore, tritoqualine has been shown to improve cognitive function and reduce amyloid beta accumulation in models of Alzheimer's disease. These findings suggest that tritoqualine could be a valuable therapeutic tool for treating a range of neurological conditions. Research is ongoing to further investigate its efficacy and safety in clinical settings.'

tritoqualine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72145
CHEMBL ID2104445
CHEBI ID135802
SCHEMBL ID28974
MeSH IDM0044812

Synonyms (49)

Synonym
tritoqualine
trq ,
livalfa
tritocualina
hypostamine
l-554
mci-5011
tritoqualine [inn:dcf]
tritoqualinum [inn-latin]
35nz
554l
hypostamin
tritoqualin
tritocualina [inn-spanish]
brn 0634993
7-amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)phthalide
inhibostamin
l 554
4,5,6-triethoxy-7-amino-3-(8-methoxy-2-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydro-1-isochinolinyl)phthalid
7-amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-1(3h)-isobenzofuranone
tritocualina [spanish]
1(3h)-isobenzofuranone, 7-amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-
D07405
tritoqualine (inn)
14504-73-5
hypostamine (tn)
CHEBI:135802
7-amino-4,5,6-triethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3h-2-benzofuran-1-one
CHEMBL2104445
tritocaline
f4mw5166yh ,
unii-f4mw5166yh
tritoqualinum
SCHEMBL28974
tritoqualine [inn]
tritoqualine [who-dd]
tritoqualine [mi]
tritoqualine [mart.]
tritoqualine [jan]
HY-U00065
CS-6602
Q3539707
7-amino-4,5,6-triethoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3h)-one
DB13711
inhibostamin;hypostamine
DTXSID10864514
EN300-19766591
7-amino-4,5,6-triethoxy-3-{4-methoxy-6-methyl-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-1,3-dihydro-2-benzofuran-1-one
AKOS040742779

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Pretreatment with Tritoqualine apparently protected the latent collagenase against ethanol activation."( Is histamine involved in ethanol-induced inflammation?
Maśliński, S; Wojtecka-Lukasik, E, 1988
)
0.6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
isoquinolinesA class of organic heteropolycyclic compound consisting of isoquinoline and its substitution derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Tritoqualine H1-Antihistamine Action87

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-199032 (96.97)18.7374
1990's1 (3.03)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.41 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (12.12%)5.53%
Reviews2 (6.06%)6.00%
Case Studies4 (12.12%)4.05%
Observational0 (0.00%)0.25%
Other23 (69.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]